These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 30305602)

  • 1. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
    Cheng T; Xu Y
    Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer of Zeste 2 (EZH2) is up-regulated in malignant gliomas and in glioma stem-like cells.
    Orzan F; Pellegatta S; Poliani PL; Pisati F; Caldera V; Menghi F; Kapetis D; Marras C; Schiffer D; Finocchiaro G
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):381-94. PubMed ID: 20946108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELK and EZH2 Cooperate to Regulate Medulloblastoma Cancer Stem-like Cell Proliferation and Differentiation.
    Liu H; Sun Q; Sun Y; Zhang J; Yuan H; Pang S; Qi X; Wang H; Zhang M; Zhang H; Yu C; Gu C
    Mol Cancer Res; 2017 Sep; 15(9):1275-1286. PubMed ID: 28536141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
    Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
    Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-type lectin domain family 5, member A (CLEC5A, MDL-1) promotes brain glioblastoma tumorigenesis by regulating PI3K/Akt signalling.
    Fan HW; Ni Q; Fan YN; Ma ZX; Li YB
    Cell Prolif; 2019 May; 52(3):e12584. PubMed ID: 30834619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2F7-EZH2 axis regulates PTEN/AKT/mTOR signalling and glioblastoma progression.
    Yang R; Wang M; Zhang G; Bao Y; Wu Y; Li X; Yang W; Cui H
    Br J Cancer; 2020 Oct; 123(9):1445-1455. PubMed ID: 32814835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
    Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of LRIG1 expression by RNA interference promotes the aggressive properties of glioma cells via EGFR/Akt/c-Myc activation.
    Xie R; Yang H; Xiao Q; Mao F; Zhang S; Ye F; Wan F; Wang B; Lei T; Guo D
    Oncol Rep; 2013 Jan; 29(1):177-84. PubMed ID: 23124613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2.
    Lee YC; Chang WW; Chen YY; Tsai YH; Chou YH; Tseng HC; Chen HL; Wu CC; Chang-Chien J; Lee HT; Yang HF; Wang BY
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.
    Zhang Y; Wang J; An W; Chen C; Wang W; Zhu C; Chen F; Chen H; Zheng W; Gong J
    Technol Cancer Res Treat; 2019; 18():1533033819854132. PubMed ID: 31138033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2.
    Yang A; Wang H; Yang X
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29046366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
    Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
    J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression.
    Cheng C; Dong Y; Ru X; Xia Y; Ji Y
    Cancer Gene Ther; 2021 Sep; 28(9):1025-1034. PubMed ID: 33293663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EZH2 is essential for glioblastoma cancer stem cell maintenance.
    Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
    Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity.
    Gao F; Du Y; Zhang Y; Ren D; Xu J; Chen D
    Gene; 2020 Feb; 726():144196. PubMed ID: 31669648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
    Li Q; Dong C; Cui J; Wang Y; Hong X
    J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. n-Butylidenephthalide Regulated Tumor Stem Cell Genes EZH2/AXL and Reduced Its Migration and Invasion in Glioblastoma.
    Yen SY; Chuang HM; Huang MH; Lin SZ; Chiou TW; Harn HJ
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2-mediated long-chain non-coding RNA LINC00963 promotes proliferation and invasion of glioma cells through inhibiting p21 expression.
    Gai Q; Guo W; Liu J
    J BUON; 2021; 26(2):380-387. PubMed ID: 34076983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling the therapeutic potential of IHMT-337 in glioma treatment: targeting the EZH2-SLC12A5 axis.
    Zhang H; Wang Z; Qiao X; Peng N; Wu J; Chen Y; Cheng C
    Mol Med; 2024 Jun; 30(1):91. PubMed ID: 38886655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
    Xu C; He T; Li Z; Liu H; Ding B
    Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.